Literature DB >> 28381867

Correlation between peak systolic velocity and diameter of cavernosal arteries in flaccid versus dynamic state for the evaluation of erectile dysfunction.

R Souper1, J Hartmann1, M Alvarez2, I Fuentes2, G Astroza1, M Marconi1.   

Abstract

Previous studies have suggested that parameters measured in the flaccid state (FS) by penile duplex Doppler ultrasound (PDDU) may predict the outcome after intracavernosal injection (ICI). The aim of this study was to evaluate the association between peak systolic velocity (PSV) and cavernosal artery diameter (CAD) in the FS with PSV and clinical assessment of erection hardness (CAEH) after ICI. Fifty patients who underwent PDDU for erectile dysfunction were prospectively enrolled. PSV and CAD were measured in FS and then correlated with PSV and CAEH after ICI of 20 μg of e1 prostaglandin (PGe1). Even though PSV in FS demonstrated a significant correlation with PSV after ICI (P=0.04, r=0.21), none of the cutoff values tested (10, 13 and 15 cm s-1 in FS) had a combined sensitivity and specificity >80% to predict a PSV after ICI ⩾30 cm s-1. No correlation was observed between CAD in FS and PSV after ICI. Also, no association was observed between PSV in FS and development of a complete full rigid erection after ICI. Although PSV in FS statistically correlates with PSV after ICI, predictive values are low, making it non-reliable to predict accurately the response to ICI of 20 μg PGe1.

Entities:  

Mesh:

Year:  2017        PMID: 28381867     DOI: 10.1038/ijir.2017.9

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  24 in total

Review 1.  Colour Doppler ultrasound of the penis.

Authors:  C J Wilkins; S Sriprasad; P S Sidhu
Journal:  Clin Radiol       Date:  2003-07       Impact factor: 2.350

2.  Norepinephrine involvement in response to intracorporeal injection of papaverine in psychogenic impotence.

Authors:  S C Kim; M M Oh
Journal:  J Urol       Date:  1992-06       Impact factor: 7.450

3.  Intracavernous self-injection of prostaglandin E1 in the treatment of erectile dysfunction.

Authors:  P Kunelius; O Lukkarinen
Journal:  Int J Impot Res       Date:  1999-02       Impact factor: 2.896

4.  Penile blood flow changes in the flaccid and erect state in potent young men measured by duplex scanning.

Authors:  B C Mellinger; E D Vaughan
Journal:  J Urol       Date:  1990-10       Impact factor: 7.450

5.  Re-dosing of prostaglandin-E1 versus prostaglandin-E1 plus phentolamine in male erectile dysfunction: a dynamic color power Doppler study.

Authors:  A Aversa; V Bonifacio; C Moretti; G Frajese; A Fabbri
Journal:  Int J Impot Res       Date:  2000-02       Impact factor: 2.896

6.  The combined intracavernous injection and stimulation test: diagnostic accuracy.

Authors:  C F Donatucci; T F Lue
Journal:  J Urol       Date:  1992-07       Impact factor: 7.450

7.  Duplex ultrasound evaluation of cavernosal peak systolic velocity and waveform acceleration in the penile flaccid state: clinical significance in the assessment of the arterial supply in patients with erectile dysfunction.

Authors:  M Mancini; M Bartolini; M Maggi; P Innocenti; N Villari; G Forti
Journal:  Int J Androl       Date:  2000-08

8.  Predictive value of cavernosal peak systolic velocity in the flaccid penis.

Authors:  N Kahvecioğlu; A Kurt; A Ipek; K R Yazicioğlu; Z Akbulut
Journal:  Adv Med Sci       Date:  2009       Impact factor: 3.287

9.  Evaluation of vasculogenic erectile impotence using penile duplex ultrasonography.

Authors:  R Shabsigh; I J Fishman; E T Quesada; C K Seale-Hawkins; J K Dunn
Journal:  J Urol       Date:  1989-12       Impact factor: 7.450

Review 10.  The epidemiology of erectile dysfunction.

Authors:  A E Benet; A Melman
Journal:  Urol Clin North Am       Date:  1995-11       Impact factor: 2.241

View more
  1 in total

Review 1.  Current approaches to the diagnosis of vascular erectile dysfunction.

Authors:  Ming Ma; Botao Yu; Feng Qin; Jiuhong Yuan
Journal:  Transl Androl Urol       Date:  2020-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.